Janux Therapeutics Inc

Janux Therapeutics, Inc. is a US-based entity in the field of biopharmaceuticals. Deploying new strategies, it develops potent and selective immunotherapies to battle cancer and other diseases worldwide. Within the healthcare sector, Janux Therapeutics operates with an emphasis on health technology, particularly in developing immuno-oncology drugs. Janux chiefly operates in the spheres of drug discovery, drug development, and clinical research, facilitating transformative immunotherapies that manipulate the immune system to fight disease. Diversify your virtual portfolio by following JANX shares on eToro.